Pear Therapeutics

Pear Therapeutics, Inc. (PEAR), is a venture-backed digital health company focused on the development of digital therapies and drug/software combinations to treat diseases with high unmet medical need.

Industries

Biotechnology

Headquarters

Boston, United States

Stage

Post IPO Equity

Employees

201-500

Links

Org chart

Corey Mccann

President & CEO

Collapse

Erin Brenner

Chief Product Development Officer

VP & CTO

VP, Patient Services

CFO & COO

Chief Medical Officer & Head of Development

Ronan O’brien

General Counsel, Chief Compliance Officer & Secretary

Catherine Cushenberry

VP, Business Programs

Beth Keyt

VP, Government Affairs & Market Access

Anthony Watson

VP, Regulatory Affairs

Chris Valosky

VP, Sales, Commercial Partnership & Marketing

Maria Sullivan

VP, Clinical Development

Martha Carruthers

VP, Corporate Development

Frances Thorndike

VP, Medical Affairs & Discovery

Teams

View all

Leadership Team

11 members

Board of Directors

2 members

CEO and Executive Team

4 members

Discover similar companies

Cytodyn

Vancouver, United States · Post IPO Equity

Regeneron

Tarrytown, United States · Post IPO Equity

Verve Therapeutics

Cambridge, United States · IPO

Biogen

Cambridge, United States

Pionyr Immunotherapeutics

South San Francisco, United States · Corporate Round

Helix

San Mateo, United States · Series C

Guardant Health

Redwood City, United States · Venture

miR Scientific

New York, United States

Genentech

South San Francisco, United States · Venture

Illumina

San Diego, United States

Scipher Medicine

Waltham, United States · Series D

Natera

Austin, United States · Post IPO Equity

The Org
helps you hire
great candidates

It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.